Novartis (Rights for Cibacen and Cibadrex) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Novartis (Rights for Cibacen and Cibadrex) General Information

Description

A portfolio of rights of two pharmaceutical drugs. The drugs mainly used for the treatment of hypertension.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Acquirer
Primary Office
  • P.O. Box CH - 4002
  • Basel
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Rights for Cibacen and Cibadrex) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Rights for Cibacen and Cibadrex)‘s full profile, request access.

Request a free trial

Novartis (Rights for Cibacen and Cibadrex) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Rights for Cibacen and Cibadrex)‘s full profile, request access.

Request a free trial